No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| RNRRenaissanceRe Holdings Ltd. | 12.54B | 271.89 | 7.72 | 28.13% | 14.31% | 9.13% | 33.22% | 0.11 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.49B | 1.73B | 2.1B | 2.06B | 4.18B | 5.16B | 5.27B | 5.05B | 9.09B | 11.65B |
| Revenue Growth % | 0.21% | 0.16% | 0.21% | -0.02% | 1.03% | 0.23% | 0.02% | -0.04% | 0.8% | 0.28% |
| Medical Costs & Claims | 686.83M | 820.15M | 2.21B | 1.55B | 2.86B | 3.82B | 5.09B | 5.91B | 5.45B | 7.98B |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 807.79M | 906.72M | -112.67M | 503.46M | 1.32B | 1.33B | 174.46M | -858.28M | 3.64B | 3.67B |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | -0.09% | 0.12% | -1.12% | 5.47% | 1.62% | 0.01% | -0.87% | -5.92% | 5.24% | 0.01% |
| Operating Expenses | 311.42M | 276.33M | 215.51M | 240.84M | 352M | 336.92M | 288.56M | 360.55M | 532.53M | 631.37M |
| OpEx / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 18.18M | 29.3M | 31.24M | 123K | -58.96M | 16.65M | -20.99M | -26.95M | -134.75M | -76.08M |
| Combined Ratio % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 496.38M | 630.39M | -328.18M | 262.62M | 967.48M | 995.92M | -114.11M | -1.22B | 3.11B | 3.04B |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -0.28% | 0.27% | -1.52% | 1.8% | 2.68% | 0.03% | -1.11% | -9.68% | 3.55% | -0.02% |
| EBITDA | 514.55M | 659.69M | -296.94M | 262.74M | 908.52M | 1.01B | -135.1M | -1.25B | 2.98B | 2.96B |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 36.27M | 42.14M | 44.19M | 47.07M | 58.36M | 50.45M | 47.54M | 48.34M | 73.18M | 93.77M |
| Non-Operating Income | -36.27M | -42.14M | -44.19M | -47.07M | -58.36M | -50.45M | -47.54M | -48.34M | -73.18M | -47.09M |
| Pretax Income | 496.38M | 630.39M | -328.18M | 262.62M | 967.48M | 995.92M | -114.11M | -1.22B | 3.11B | 2.99B |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | -45.87M | 340K | 26.49M | -6.3M | 17.21M | 2.86M | -10.67M | -59.02M | -510.07M | 32.63M |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 431.19M | 502.96M | -222.39M | 227.36M | 748.8M | 762.4M | -40.16M | -1.06B | 2.56B | 1.87B |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -0.19% | 0.17% | -1.44% | 2.02% | 2.29% | 0.02% | -1.05% | -25.43% | 3.41% | -0.27% |
| EPS (Diluted) | 9.28 | 11.43 | -5.58 | 5.72 | 16.29 | 15.31 | -1.57 | -25.50 | 52.27 | 35.21 |
| EPS Growth % | -0.26% | 0.23% | -1.49% | 2.03% | 1.85% | -0.06% | -1.1% | -15.24% | 3.05% | -0.33% |
| EPS (Basic) | 9.36 | 11.50 | -5.58 | 5.72 | 16.32 | 15.34 | -1.57 | -25.50 | 52.40 | 35.31 |
| Diluted Shares Outstanding | 43.53M | 41.56M | 39.85M | 39.76M | 43.17M | 47.18M | 47.17M | 43.04M | 47.61M | 51.34M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 11.56B | 12.35B | 15.23B | 18.68B | 26.33B | 30.82B | 33.96B | 36.55B | 49.01B | 50.71B |
| Asset Growth % | 0.41% | 0.07% | 0.23% | 0.23% | 0.41% | 0.17% | 0.1% | 0.08% | 0.34% | 0.03% |
| Total Investment Assets | 9B | 9.32B | 9.5B | 11.89B | 21.9B | 25.26B | 24.75B | 25.7B | 32.31B | 32.64B |
| Long-Term Investments | 8.97B | 9.29B | 9.49B | 11.86B | 17.33B | 20.26B | 19.45B | 21.03B | 27.7B | 28.11B |
| Short-Term Investments | 1.23B | 1.37B | 991.86M | 2.59B | 4.57B | 4.99B | 5.3B | 4.67B | 4.6B | 4.53B |
| Total Current Assets | 10.28B | 2.78B | 3.66B | 7.86B | 11.41B | 13.12B | 15.59B | 587.13M | 7.41B | 1.68B |
| Cash & Equivalents | 506.88M | 421.16M | 1.36B | 1.11B | 1.38B | 1.74B | 1.86B | 1.19B | 1.88B | 1.68B |
| Receivables | 1000K | 0 | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 2.76B | 0 | 0 | 0 | 8.51B | 0 | 10.89B | -441.33M | -13.25B | -16.39B |
| Goodwill & Intangibles | 265.15M | 251.19M | 243.15M | 237.42M | 262.23M | 249.64M | 243.5M | 237.83M | 775.35M | 704.13M |
| Goodwill | 197.59M | 197.59M | 197.59M | 197.59M | 210.68M | 211.01M | 206.32M | 206.29M | 300.54M | 300.51M |
| Intangible Assets | 67.56M | 53.6M | 45.55M | 39.83M | 51.54M | 38.63M | 37.18M | 31.53M | 474.81M | 403.63M |
| PP&E (Net) | 0 | -94.4M | -73.42M | 11.98B | 62.6M | 47.8M | 50.9M | 83.7M | 89.5M | 0 |
| Other Assets | -7.96B | 30.6M | 1.84B | -12.1B | -222.65M | -1.2B | -167.91M | -16.32B | -89.5M | -27.41B |
| Total Liabilities | 5.78B | 6.31B | 9.54B | 11.58B | 17.29B | 19.87B | 23.78B | 26.69B | 33.45B | 33.16B |
| Total Debt | 966.08M | 948.66M | 989.62M | 991.13M | 1.38B | 1.14B | 1.17B | 1.17B | 1.96B | 1.89B |
| Net Debt | 459.19M | 527.51M | -371.97M | -116.8M | 5.04M | -600.55M | -690.67M | -23.9M | 81.14M | 210.09M |
| Long-Term Debt | 966.08M | 948.66M | 989.62M | 991.13M | 1.38B | 1.14B | 1.14B | 1.14B | 1.88B | 1.44B |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 30M | 30M | 75M | 449.81M |
| Total Current Liabilities | 5.86B | 6.54B | 9.85B | 1.9B | 18.97B | 3.49B | 3.89B | 111.84M | 0 | 20.23B |
| Accounts Payable | 523.97M | 673.98M | 989.09M | 1.9B | 2.83B | 3.49B | 3.86B | 3.93B | 3.19B | 2.8B |
| Deferred Revenue | 0 | -500M | 0 | 0 | 2.33B | 0 | 0 | 0 | 661.61M | 0 |
| Other Current Liabilities | -915.35M | -479.7M | -1.2B | -2.28B | 13.59B | -1.13B | -1.17B | -4.34B | -4.58B | 16.82B |
| Deferred Taxes | 0 | 1000K | 1000K | 1000K | 1000K | 0 | 1000K | 1000K | 0 | 0 |
| Other Liabilities | -5.58M | 0 | 0 | 910.93M | 0 | 0 | 0 | 153.67M | 31.57B | 449.81M |
| Total Equity | 5.78B | 6.04B | 5.69B | 7.1B | 9.04B | 10.95B | 10.18B | 9.86B | 15.56B | 17.55B |
| Equity Growth % | 0.16% | 0.05% | -0.06% | 0.25% | 0.27% | 0.21% | -0.07% | -0.03% | 0.58% | 0.13% |
| Shareholders Equity | 4.73B | 4.87B | 4.39B | 5.05B | 5.97B | 7.56B | 6.62B | 5.33B | 9.45B | 10.57B |
| Minority Interest | 1.05B | 1.18B | 1.3B | 2.05B | 3.07B | 3.39B | 3.55B | 4.54B | 6.1B | 6.98B |
| Retained Earnings | 3.78B | 4.21B | 3.91B | 4.06B | 4.71B | 5.37B | 5.23B | 4.07B | 6.52B | 8.28B |
| Common Stock | 43.7M | 41.19M | 40.02M | 42.21M | 44.15M | 50.81M | 44.45M | 43.72M | 52.69M | 50.18M |
| Accumulated OCI | 2.11M | 1.13M | 224K | -1.43M | -1.94M | -12.64M | -10.91M | -15.46M | -14.21M | -14.76M |
| Return on Equity (ROE) | 0.08% | 0.09% | -0.04% | 0.04% | 0.09% | 0.08% | -0% | -0.11% | 0.2% | 0.11% |
| Return on Assets (ROA) | 0.04% | 0.04% | -0.02% | 0.01% | 0.03% | 0.03% | -0% | -0.03% | 0.06% | 0.04% |
| Equity / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / Equity | 0.17x | 0.16x | 0.17x | 0.14x | 0.15x | 0.10x | 0.11x | 0.12x | 0.13x | 0.11x |
| Book Value per Share | 132.75 | 145.39 | 142.72 | 178.51 | 209.44 | 232.07 | 215.78 | 229.10 | 326.75 | 341.88 |
| Tangible BV per Share | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 414.74M | 469.83M | 1.05B | 1.22B | 2.14B | 1.99B | 1.23B | 1.6B | 1.91B | 4.16B |
| Operating CF Growth % | -0.37% | 0.13% | 1.23% | 0.17% | 0.75% | -0.07% | -0.38% | 0.3% | 0.19% | 1.18% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 542.24M | 630.05M | -354.67M | 268.92M | 950.27M | 993.06M | -103.44M | -1.16B | 3.62B | 2.96B |
| Depreciation & Amortization | 18.18M | 29.3M | 31.24M | 123K | -58.96M | 16.65M | -20.99M | -26.95M | -134.75M | 258.46M |
| Stock-Based Compensation | 38.3M | 47.4M | 37.2M | 35.7M | 0 | 43.7M | 40M | 45.2M | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -43.7M | -40M | -45.2M | 0 | 0 |
| Other Non-Cash Items | 72.81M | -147.37M | -154.26M | 179.61M | -414.87M | -788.83M | 219.1M | 1.65B | -490.44M | -20.4M |
| Working Capital Changes | -218.49M | -42.16M | 1.52B | 773.05M | 1.66B | 1.77B | 1.14B | 1.14B | -1.08B | 966.24M |
| Cash from Investing | -339.04M | -164.53M | -142.43M | -2.54B | -2.99B | -2.3B | -816.3M | -3.02B | -3.82B | -3.06B |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 2.3B | 816.3M | -481.3M | 0 | 0 |
| Acquisitions | -688.3M | -2.99M | 260.48M | -13.01M | -267.67M | 142.3M | -15.49M | 1.48M | -1.89B | -15.99M |
| Purchase of Investments | -9.68B | -8.35B | -10.11B | -13.93B | -20.03B | -17.63B | -16.55B | -25.74B | -25.03B | -59.48B |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Investing | 4.5M | 400K | -122.43M | 2.5M | -4.11M | -2.3B | -816.3M | 481.3M | -539.06M | 57.34M |
| Cash from Financing | -83.67M | -386.39M | 28.86M | 1.07B | 1.12B | 665.21M | -302.46M | 725.34M | 2.59B | -1.29B |
| Dividends Paid | -76.35M | -73.96M | -73.75M | -82.93M | -96.12M | -99.41M | -100.72M | -100.07M | -110.49M | -116.22M |
| Share Repurchases | -259.87M | -309.43M | -188.59M | 0 | 0 | -187.62M | -1.3B | -166.66M | 0 | -666.92M |
| Stock Issued | 0 | 0 | 0 | 250M | 0 | 1.1B | 488.65M | 0 | 1.35B | 0 |
| Debt Issuance (Net) | 1000K | 0 | 1000K | 0 | 1000K | -1000K | 1000K | 0 | 1000K | -1000K |
| Other Financing | -203.28M | -2.99M | 245.34M | 657.82M | 819.83M | 106.74M | 582.11M | 992.08M | 561.94M | -429.37M |
| Net Change in Cash | -18.7M | -85.73M | 940.43M | -253.67M | 271.15M | 357.75M | 122.21M | -664.68M | 683.18M | -200.91M |
| Exchange Rate Effect | -1000K | -1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K |
| Cash at Beginning | 525.58M | 506.88M | 421.16M | 1.36B | 1.11B | 1.38B | 1.74B | 1.86B | 1.19B | 1.88B |
| Cash at End | 506.88M | 421.16M | 1.36B | 1.11B | 1.38B | 1.74B | 1.86B | 1.19B | 1.88B | 1.68B |
| Free Cash Flow | 414.74M | 469.83M | 1.05B | 1.22B | 2.14B | 4.3B | 2.05B | 1.12B | 1.91B | 4.16B |
| FCF Growth % | -0.37% | 0.13% | 1.23% | 0.17% | 0.75% | 1.01% | -0.52% | -0.45% | 0.7% | 1.18% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF per Share | 9.53 | 11.31 | 26.24 | 30.73 | 49.5 | 91.09 | 43.48 | 26.08 | 40.15 | 81.12 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 66.79% | 63.5% | 115.66% | 87.23% | 76.85% | 80.68% | 102.17% | 124.14% | 65.79% | 73.9% |
| Medical Cost Ratio | 45.95% | 47.49% | 105.38% | 75.52% | 68.42% | 74.15% | 96.69% | 117% | 59.93% | 68.48% |
| Return on Equity (ROE) | 8% | 8.51% | -3.79% | 3.56% | 9.28% | 7.63% | -0.38% | -10.59% | 20.15% | 11.3% |
| Return on Assets (ROA) | 4.36% | 4.21% | -1.61% | 1.34% | 3.33% | 2.67% | -0.12% | -3.01% | 5.99% | 3.75% |
| Equity / Assets | 49.98% | 48.92% | 37.36% | 38% | 34.34% | 35.52% | 29.97% | 26.98% | 31.74% | 34.61% |
| Book Value / Share | 132.75 | 145.39 | 142.72 | 178.51 | 209.44 | 232.07 | 215.78 | 229.1 | 326.75 | 341.88 |
| Debt / Equity | 0.17x | 0.16x | 0.17x | 0.14x | 0.15x | 0.10x | 0.11x | 0.12x | 0.13x | 0.11x |
| Revenue Growth | 21.12% | 15.54% | 21.36% | -1.87% | 103.2% | 23.37% | 2.14% | -4.11% | 80.05% | 28.13% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Casualty and Specialty | - | 682.34M | 786.5M | 925.3M | 1.71B | 2.02B | 2.59B | 3.56B | 4.38B | 6.25B |
| Casualty and Specialty Growth | - | - | 15.27% | 17.65% | 84.90% | 17.85% | 28.25% | 37.82% | 22.91% | 42.58% |
| Property | - | 720.95M | 931.07M | 1.05B | 1.63B | 1.94B | 2.61B | 2.77B | 3.09B | 3.85B |
| Property Growth | - | - | 29.14% | 12.86% | 54.88% | 18.97% | 34.71% | 6.21% | 11.57% | 24.57% |
| Others | -48K | - | - | - | - | - | - | - | - | - |
| Others Growth | - | - | - | - | - | - | - | - | - | - |
| Catastrophe Reinsurance | 622.71M | - | - | - | - | - | - | - | - | - |
| Catastrophe Reinsurance Growth | - | - | - | - | - | - | - | - | - | - |
| Specialty Reinsurance | 548.81M | - | - | - | - | - | - | - | - | - |
| Specialty Reinsurance Growth | - | - | - | - | - | - | - | - | - | - |
| Lloyds | 229.07M | - | - | - | - | - | - | - | - | - |
| Lloyds Growth | - | - | - | - | - | - | - | - | - | - |
RenaissanceRe Holdings Ltd. (RNR) has a price-to-earnings (P/E) ratio of 7.7x. This may indicate the stock is undervalued or faces growth challenges.
RenaissanceRe Holdings Ltd. (RNR) grew revenue by 28.1% over the past year. This is strong growth.
Yes, RenaissanceRe Holdings Ltd. (RNR) is profitable, generating $1.73B in net income for fiscal year 2024 (16.1% net margin).
Yes, RenaissanceRe Holdings Ltd. (RNR) pays a dividend with a yield of 0.58%. This makes it attractive for income-focused investors.
RenaissanceRe Holdings Ltd. (RNR) has a return on equity (ROE) of 11.3%. This is reasonable for most industries.
RenaissanceRe Holdings Ltd. (RNR) has a combined ratio of 73.9%. A ratio below 100% indicates underwriting profitability.